Danaher (DHR) reported fiscal Q1 non-GAAP net earnings Tuesday of $1.88 per diluted share, down from $1.92 a year earlier.
Analysts polled by FactSet expected $1.63.
Sales for the fiscal quarter ended March 28 were $5.74 billion, down from $5.80 billion a year earlier.
Analysts surveyed by FactSet expected $5.57 billion.
For fiscal 2025, the life sciences company expects adjusted diluted EPS of $7.60 to $7.75.
Analysts polled by FactSet expect $7.66.
Shares of the company were up more than 2% in recent premarket activity.
Price: 190.00, Change: +5.04, Percent Change: +2.72
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.